Loading
HKSEHealthcareMedical - Care Facilities
Latest quote
HK$17.98
−HK$0.23 · -1.26%
Beauty Farm Medical and Health Industry Inc., established in 1993 and based in Shanghai, People's Republic of China, delivers comprehensive beauty and health management services across China. Its diverse offerings encompass traditional beauty treatments; advanced aesthetic medical services, including non-surgical options like energy-based therapies and injections, as well as surgical procedures; and specialized subhealth assessment and intervention programs. As of June 30, 2022, the company operated a network of 352 stores under its BeautyFarm, Palaispa, Neology, and CellCare brands, with 177 being directly owned and 175 franchised.
Latest quote
HK$17.98
−HK$0.23 · -1.26%
Regular session · HKT · Market data may be delayed.
Beauty Farm Medical and Health Industry Inc., established in 1993 and based in Shanghai, People's Republic of China, delivers comprehensive beauty and health management services across China. Its diverse offerings encompass traditional beauty treatments; advanced aesthetic medical services, including non-surgical options like energy-based therapies and injections, as well as surgical procedures; and specialized subhealth assessment and intervention programs. As of June 30, 2022, the company operated a network of 352 stores under its BeautyFarm, Palaispa, Neology, and CellCare brands, with 177 being directly owned and 175 franchised.
Day range
Current HK$17.98
52-week range
Current HK$17.98
Regular session · HKT · Market data may be delayed.
Beauty Farm Medical and Health Industry Inc., established in 1993 and based in Shanghai, People's Republic of China, delivers comprehensive beauty and health management services across China. Its diverse offerings encompass traditional beauty treatments; advanced aesthetic medical services, including non-surgical options like energy-based therapies and injections, as well as surgical procedures; and specialized subhealth assessment and intervention programs. As of June 30, 2022, the company operated a network of 352 stores under its BeautyFarm, Palaispa, Neology, and CellCare brands, with 177 being directly owned and 175 franchised.
Day range
Current HK$17.98
52-week range
Current HK$17.98
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (CNY) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3B CNY | 2.57B CNY | 2.15B CNY | 1.64B CNY | 1.78B CNY |
| Cost of goods sold | 1.53B CNY | 1.38B CNY | 1.17B CNY | 917.57M CNY | 946.95M CNY |
| Gross profit | 1.47B CNY | 1.19B CNY | 977.1M CNY | 717.84M CNY | 833.79M CNY |
| Research and development | 41.94M CNY | 36.03M CNY | 34.07M CNY | 31.19M CNY | 18.03M CNY |
| Selling, general, and administrative | 992.71M CNY | 849.84M CNY | 166.85M CNY | 171.12M CNY | 148.57M CNY |
| Operating expenses | 1.01B CNY | 868.17M CNY | 685.81M CNY | 565.75M CNY | 555.75M CNY |
| Interest income | 22.71M CNY | 23.62M CNY | 21.84M CNY | 3.09M CNY | 1.28M CNY |
| Interest expense | 32.16M CNY | 27.56M CNY | 24.81M CNY | 24.71M CNY | 24.22M CNY |
| Depreciation and amortization | 151.71M CNY | 117.35M CNY | 331.74M CNY | 297.24M CNY | 275.19M CNY |
| Operating income | 459.52M CNY | 321.82M CNY | 291.29M CNY | 152.09M CNY | 278.04M CNY |
| Net income | 317.56M CNY | 228.46M CNY | 215.66M CNY | 103.11M CNY | 193.48M CNY |
Company facts updated Sep 11, 2026.
Recent quarterly results
Recent quarterly results
Cash distributions grouped by calendar year; partial years are marked.
HK$0.52
2025 complete year+33.3% since 2023
2026 partial: HK$0.72
HK$0.39
2,023
HK$0.47
2,024
HK$0.52
2,025
HK$0.72
2,026*
* Partial calendar year in the available dividend history.
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
Dividend | Aug 19, 2026 | HK$0.72Annual | Aug 21, 2026 | Sep 28, 2026 |
Dividend | Aug 19, 2025 | HK$0.52Annual | Aug 21, 2025 | Sep 25, 2025 |
Dividend | Jul 2, 2024 | HK$0.47Annual | Jul 3, 2024 | Sep 25, 2024 |
Dividend | Jun 21, 2023 | HK$0.39Annual | Jun 23, 2023 | Sep 28, 2023 |
Ex-dividend Aug 19, 2026
HK$0.72
Annual
Record Aug 21, 2026 · Payment Sep 28, 2026
Ex-dividend Aug 19, 2025
HK$0.52
Annual
Record Aug 21, 2025 · Payment Sep 25, 2025
Ex-dividend Jul 2, 2024
HK$0.47
Annual
Record Jul 3, 2024 · Payment Sep 25, 2024
Ex-dividend Jun 21, 2023
HK$0.39
Annual
Record Jun 23, 2023 · Payment Sep 28, 2023
Funds reporting this stock among their holdings, ordered by reported position size.
Dimensional - Emerging Core Equity Market ETFDFAE82.44K0.00%10.29B USD0.29%$40.15+1.29%
State Street SPDR S&P Emerging Markets Small Cap ETFEWX67.86K0.01%689.81M USD0.65%$72.645+0.35%
Avantis Emerging Markets Small Cap Equity ETFAVEE21.49K0.02%141.01M USD0.42%$69.18+0.87%
Dimensional - Emerging Markets Core Equity 2 ETFDFEM19.74K0.00%9.74B USD0.39%$40.545+1.16%Dimensional - Emerging Core Equity Market ETFDFAEState Street SPDR S&P Emerging Markets Small Cap ETFEWXAvantis Emerging Markets Small Cap Equity ETFAVEEDimensional - Emerging Markets Core Equity 2 ETFDFEMAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
